Shares of cancer-therapy companies skyrocket after Pfizer acquisition news
June 17, 2019 at 13:25 PM EDT
Shares of gene-therapy companies shot up on Monday after Pfizer Inc. announced it would acquire cancer drug maker Array BioPharma Inc. in a deal worth up to $11.4 billion.
